—> Breaking News- ACOL releases Strong Sales (Emerging growth continues!)

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

StockRunway Newsletter

Good Morning Traders, As things stand no wishing is needed and you have a very good chance to buy some of this delightfully attractive stock – for just ..11. Liquidity levels are decent enough for swift movement and the stock is so oversold at the moment, it provides enough bounce potential to take 10 NASA rockets into orbit.

Now add more fuel on the fire…this mornings Breaking News just released regarding increasing demand for it`s signature product and exceeding expectations of sales! The main product is a trademark container called The Medtainer(TM), and it`s been getting some strong attention over the last few weeks. Altura Pharmaceuticals is in discussions with the company about an 8 state distribution agreement should become a huge draw…Start your research immediately if you have not done so already..

► The Runway`s New Low-Float Pick:

► Acology, Inc. – Ticker: ACOL Breaking News: Acology Inc. Announces Upbeat November Sales Results, Forecasts Strong 2015 Ahead! CORONA, CA–(Marketwired – December 04, 2014) – Acology Inc.

(ACOL) has announced that November sales have exceeded expectations. Increases in demand for its signature product, “The MedTainer(TM)”, has essentially led to product shortages. This amplified demand has left Acology with the necessity of increasing the manufacture of the popular pharmaceutical containers to keep up with demand.

Although Acology`s manufacturing capabilities have not yet reached capacity, as orders continue to surge the possibility of production shortfalls has forced Acology to consider acquiring additional manufacturing equipment to meet the increasing demand.

CEO Curt Fairbrother states, “It`s a good problem to have. We anticipated that once we moved into our new production facility we might encounter an additional wave in demand. Fortunately we are in a good financial position, and if we need to raise capital we have sources that can give us some assistance as we need it. In the event that we attain one of the national contracts that we are in talks for, like a pharmaceutical chain or pet outlet, we`ll be in a position to decisively deal with it. We will be able to keep up, and we like the position that we`re in.” Acology is bullish on 2015 futures and sees the potential for strong earnings in the 1st quarter.

Read the full Breaking News source right here:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3mxuYldwP1976pl&b=GLXHpQk7ssqfK9hy314FHw ACOL: Three Massive Catalysts to Consider 1. ACOL is trading ridiculously cheap at the moment and represents tremendous value at current levels based on past price tags coupled with current direction of the company business model.

2. Today`s Breaking News confirms demand of it`s signature product Medtainer(TM) which is on the cusp of a commercial breakthrough and the value-implications are already sending the stock higher.

3. ACOL has a tiny market cap – expect Wall Street to notice the bargain at just .11 a share.A low-float type play such as this one could potentially provide traders significant returns in a short term period if momentum engages.

Make sure ACOL gets your undivided attention.

ACOL Gets Thunderous Invite to American Music Awards ACOL said in a recent release that its Medtainer(TM) was selected to be a part of the Honorary 2014 American Music Awards (AMAs) Celebrity Gift Bag Giveaway. The AMAs were broadcast LIVE from the Nokia Theater L.A. on November 23rd, 2014.

The AMAs features over 15 musical performances from today`s hottest artists and presents fan-voted awards in the categories of Pop/Rock, Alternative Rock, Country, Rap/Hip-Hop, Soul/R&B, Adult Contemporary, Contemporary Inspirational, Latin, EDM, New Artist of the Year, and Artist of the Year.

ACOL is also in discussions with Altura Pharmaceuticals of Santa Fe Springs about distributing the company`s flagship Medtainer(TM). Altura Pharmaceuticals currently does business in 8 states, including California and Arizona, and holds both state and federal licenses for handling, packaging and shipping a wide-array of pharma products to public and private institutions and end-users.

You can see the rest of the release here:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3mxuYldwP1976pl&b=cGO7sJYItuH5RIQl3krIcw ACOL: Could Today`s Warm-up Lead Tomorrow`s Heated Rally ACOL: Have you seen bounce potential this good in the 2014 trading year http://clicks.aweber.com/y/ct/l=4k3kt&m=3mxuYldwP1976pl&b=xfgsr4dvE63XQhOXLSK.Wg ACOL`s chart shows an oversold RSI of 36. Bounce potential at this level is simply sublime and definitely not something a savvy trader can afford to let slip by.

There`s some negative divergence on the MACD but if you look at the chart you see that the crossovers are inching closer and closer to the zero line. A break above zero and ACOL is probably too expensive for you to catch. In other words, the time for entry looks to be now.

Volume on this monster (yes, with a 12-month high of $5 we are talking Godzilla here) is tight. Average volume is 20K, but when ACOL shifts it does so with heavyweight pricing! Current market valuation of just .11 a share should be taken as a massive opportunity – a discount quite unlike anything you`ll see for a setup like this.

Make no mistake, there are a number of important factors to consider when leaning towards one great trade idea over another, but what can`t be denied is the incredible gain potential of ACOL based on past history.

For this reason, I am urging all members to begin your research on this emerging small-cap without delay hence to be ready for ACOL tomorrow morning!The Crew Chief www.StockRunway.com info@StockRunway.com Copyright 2010 StockRunway.com All Rights Reserved. Protected by copyright laws of the United States and international treaties.

This email may only be used pursuant to the subscription agreement controlling use of the StockRunway financial web site and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of StockRunway.com.

LEGAL DISCLAIMER: Neither StockRunway nor any of its employees are registered investment advisors or a Broker/Dealer. As such, StockRunway does not offer or provide personalized investment insight. Although StockRunway may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees to you should be considered personalized investment insight.

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

StockRunway.com is often times compensated to feature certain companies. These third party, may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Release of Liability: Through use of this website viewing or using you agree to hold StockRunway.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

StockRunway.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockRunway.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockRunway.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks.

Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

StockRunway.com is compliant with the Can Spam Act of 2003.

StockRunway.com does not offer such advice or analysis, StockRunway.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.These are paid advertisements used to generate exposure and awareness about the company or companies mentioned in our newsletters.

For full disclaimer please visit our website:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3mxuYldwP1976pl&b=Xv0GxRMm_ds8GLfzrczcuQ Our Ace Pilot lives by one simple measure of success…Yours! 4940 Merrick Rd. Suite 128 Massapequa Park, New York 11758 To

This entry was posted in StockRunway and tagged . Bookmark the permalink.

Comments are closed.